Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential


Recent & Breaking News (TSX:EDT)

Spectral Medical Announces Third Quarter Results and Provides Corporate Update

GlobeNewswire November 10, 2022

Spectral Medical (TSX:EDT) closes $10.8M public offering and concurrent private placement

Azuka Onwuka November 2, 2022

Spectral Medical Inc. Closes $10.8 Million Public Offering and Concurrent Private Placement

GlobeNewswire November 2, 2022

Spectral Medical Inc. Announces Pricing of Previously Announced Offering

GlobeNewswire October 6, 2022

Spectral Medical Inc. Announces Proposed Public Offering of Units and Private Placement of Notes

GlobeNewswire October 5, 2022

Spectral Medical (TSX: EDT) provides Tigris clinical trial update

Sabrina Cuthbert October 4, 2022

Spectral Medical Provides Update on Tigris Clinical Trial

GlobeNewswire October 4, 2022

Spectral (TSX:EDT) gets FDA approval for Tigris trial

Caroline Egan  August 18, 2022

Spectral Announces FDA Approval to Add Up to 10 Additional Tigris Clinical Trial Sites

GlobeNewswire August 18, 2022

Spectral Medical (TSX:EDT) reports Q2 2022 results

Jon Brown August 12, 2022

Spectral Announces Second Quarter Results and Provides Corporate Update

GlobeNewswire August 12, 2022

Spectral Medical (TSX:EDT) subsidiary Dialco Medical and Marathon Medical awarded contract with the U.S. Department of Veterans Affairs

John Ballem  August 8, 2022

Spectral Medical Announces that its Wholly-Owned Subsidiary Dialco Medical and Distribution Partner Marathon Medical Awarded Contract to Provide SAMI Dialysis Devices to the US Department of Veterans Affairs

GlobeNewswire August 8, 2022

Spectral Medical's Chief Medical Officer, Dr. John Kellum, to be the Featured Speaker in Webinar Hosted by Sepsis Alliance

GlobeNewswire July 26, 2022

Spectral Medical (TSX:EDT) reports success of Tigris clinical trial

Jon Brown July 20, 2022

Spectral Medical Provides Update on Tigris Clinical Trial

GlobeNewswire July 20, 2022

Spectral Medical Highlights From Vicenza Course 2022

GlobeNewswire July 14, 2022

Spectral Medical to Participate at the Benzinga All Access event on July 15, 2022

GlobeNewswire July 13, 2022

Spectral Medical's (TSX:EDT) Toraymyxin receives Breakthrough Device Designation

John Ballem  July 11, 2022

US FDA Grants Spectral Medical Breakthrough Device Designation for Toraymyxin(TM) ("PMX") for the Treatment of Endotoxemic Septic Shock

GlobeNewswire July 11, 2022